It promotes blood vessel health, improves blood flow, and assists in reducing inflammation, which can often contribute to heart disease (12)
Implications for Clinical Practice and Future Research At present, GLP-1 receptor agonists remain the primary evidence-supported pharmacologic option for adolescents with obesity
Phenotype-Guided Therapy The emergence of SGLT2is and GLP-1RAs as disease-modifying therapies has shifted treatment paradigms in T2D toward phenotype-guided treatment strategies
With strategic, integrated care, patients can get the benefits of using GLP-1 drugs without the debilitating side effects, and employers and health plans can manage the costs associated with GLP-1s without impacting the health of the people they serve
Each compound has a distinct receptor selectivity profile and pharmacokinetic curve, allowing researchers to isolate specific aspects of GLP-1 signaling in study design
Measurement of oxidatively induced DNA damage and its repair, by mass spectrometric techniques